The saudi arabia bariatric surgery market size was valued at USD 61.86 million in 2025 and estimated to grow from USD 66.82 million in 2026 to reach USD 98.28 million by 2031, at a CAGR of 8.02% during the forecast period (2026-2031). This report is Segmented by Device (Assisting Devices, Implantable Devices, Other Devices), Procedure (Sleeve Gastrectomy, Gastric Bypass, Adjustable Gastric Banding, Intragastric Balloon & Endo-Stapling, Others), and End User (Hospitals, Specialized Bariatric Centers/Clinics, Ambulatory Surgical Centers). The Market Forecasts are Provided in Terms of Value (USD).
Gastric Balloons, growing at 9.31% CAGR, attract lower-BMI patients seeking reversible options. Local clinics market the procedure aggressively to corporate wellness programs, broadening intake channels. Suturing Devices retain a niche but essential role in revision surgeries. Electrical Stimulation Systems remain small yet meaningful for high-risk cohorts unsuitable for staples. Domestic manufacturers pursue SFDA approvals for adjunct accessories, aligning with Vision 2030 targets to localize production and lift healthcare self-sufficiency.
Saudi Arabia Bariatric Surgery Market Trends and Insights
Rising Prevalence of Obesity Drives Surgical Demand
Adult obesity exceeded 40.6% in 2025, translating to more than 1.9 million candidates for metabolic procedures. Saudi clinical guidelines place surgery as first-line therapy for BMI ≥ 40 kg/m² or BMI ≥ 35 kg/m² with comorbidities, so procedure volumes climb faster than population growth. Urban dietary shifts and sedentary employment amplify prevalence in working-age cohorts, sustaining patient flow into high-volume centers. Obesity-related healthcare spending reached USD 110.6 billion in 2022, and cost-utility models show bariatric surgery at USD 31,909 per QALY, well within accepted thresholds, reinforcing payer willingness to reimburse.Vision 2030 Healthcare Infrastructure Investments Accelerate Market Growth
The government allocated SAR 65 billion (USD 17.3 billion) to expand surgical capacity through 2030. Projects such as Saudi German Hospital Makkah add 300 beds and dedicated operating suites, while plans to privatize 290 hospitals and 2,300 primary centers widen private sector roles. Digital initiatives like Seha Virtual Hospital enable remote pre-operative screening and follow-up, supporting the Saudi Arabia Bariatric Surgery market across underserved regions. These investments underpin long-run procedure growth beyond demographic effects.High Procedure Costs Create Access Barriers
Robotic stapling adds a 47% premium over laparoscopy, raising direct device cost from USD 1,477 to USD 2,175 per case. Body-contouring surgeries remain self-paid for 94.1% of post-bariatric patients, revealing price elasticity even among high-BMI groups. Small hospitals shoulder SFDA registration fees that inflate procurement budgets and ultimately patient bills, especially where insurance ceilings are lower than actual invoices.Other drivers and restraints analyzed in the detailed report include:
- Enhanced Recovery After Surgery Protocols Transform Operational Efficiency
- National Health Insurance Coverage Expansion Broadens Patient Access
- Workforce Development Challenges Constrain Service Expansion
Segment Analysis
Stapling Devices accounted for 35.12% of Saudi Arabia Bariatric Surgery market share in 2025 as they are integral to sleeve gastrectomy and gastric bypass workflows. The launch of the ETHICON 4000 Stapler in 2025 tightens staple-line security and is expected to defend share against multi-fire platforms introduced by competitors. Energy/Vessel-sealing Devices rise in tandem with robotic penetration, while Trocars & Access Instruments benefit from the procedural shift toward laparoscopy and reduced incision profiles.Gastric Balloons, growing at 9.31% CAGR, attract lower-BMI patients seeking reversible options. Local clinics market the procedure aggressively to corporate wellness programs, broadening intake channels. Suturing Devices retain a niche but essential role in revision surgeries. Electrical Stimulation Systems remain small yet meaningful for high-risk cohorts unsuitable for staples. Domestic manufacturers pursue SFDA approvals for adjunct accessories, aligning with Vision 2030 targets to localize production and lift healthcare self-sufficiency.
Complete Report Scope:
- By Device
- Assisting Devices
- Suturing Devices
- Closure Devices
- Stapling Devices
- Trocars & Access Instruments
- Energy / Vessel-sealing Devices
- Implantable Devices
- Gastric Balloons
- Gastric Bands
- Electrical Stimulation Systems
- Other Devices (Robotic & Endoluminal Platforms)
- Assisting Devices
- By Procedure
- Sleeve Gastrectomy
- Gastric Bypass
- Adjustable Gastric Banding
- Intragastric Balloon & Endo-Stapling
- Others
- By End User
- Hospitals
- Specialised Bariatric Centers / Clinics
- Ambulatory Surgical Centers
List of Companies Covered in this Report:
- Johnson & Johnson
- Medtronic
- Apollo Endosurgery
- Intuitive Surgical
- B. Braun
- Conmed
- Olympus
- The Cooper Companies
- Stryker
- Beckton Dickinson
- Teleflex
- Karl Storz SE
- W. L. Gore & Associates
- Spatz Medical
- Allurion Technologies
- ReShape LifeSciences
- Aspire Bariatrics
- Enteromedics (Electro-Stimulation)
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
1 Introduction
4 Market Landscape
5 Market Size & Growth Forecasts (Value)
6 Competitive Landscape
7 Market Opportunities & Future Outlook
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Johnson & Johnson (Ethicon)
- Medtronic plc
- Apollo Endosurgery Inc.
- Intuitive Surgical Inc.
- B. Braun SE
- Conmed Corporation
- Olympus Corporation
- CooperSurgical Inc.
- Stryker Corporation
- Becton Dickinson & Company
- Teleflex Incorporated
- Karl Storz SE
- W. L. Gore & Associates
- Spatz Medical
- Allurion Technologies
- ReShape LifeSciences
- Aspire Bariatrics
- Enteromedics (Electro-Stimulation)
